Adulteration of the unregulated opioid supply has contributed to increasing numbers of overdose deaths in North America. Harm-reduction drug checking has emerged as a strategy to address increasing adulteration rates by providing information about sample composition to people who use drugs. While paper-spray mass spectrometry is capable of trace detection for drug checking, the presence of newly emerging substances often goes undetected if not included in the targeted analysis method. High-resolution mass spectrometry has not been widely used in drug-checking efforts to date, but it has advanced capabilities to facilitate the detection of newly emerging substances. We present a high-resolution paper-spray mass spectrometry method developed for the detection of newly emerging compounds in the street-drug supply. The method was used to analyze a selection of opioid samples received at a drug-checking service in Victoria, British Columbia, Canada. Using this approach, newly emerging adulterants, precursors and byproducts were identified in the local street-drug supply.
No takes yet. Share an insight, caveat, or question.
Miskulin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: